Ontology highlight
ABSTRACT: Background and aims
The recognition of transarterial chemoembolization (TACE) failure/refractoriness among Chinese clinicians remains unclear. Using an online survey conducted by the Chinese College of Interventionalists (CCI), the aim of this study was to explore the recognition of TACE failure/refractoriness and review TACE application for hepatocellular carcinoma (HCC) treatment in clinical practice.Methods
From 27 August 2020 to 30 August 2020 during the CCI 2020 annual meeting, a survey with 34 questions was sent by email to 264 CCI clinicians in China with more than 10 years of experience using TACE for HCC treatment.Results
A total of 257 clinicians participated and responded to the survey. Most participants agreed that the concept of "TACE failure/refractori
SUBMITTER: Zhong BY
PROVIDER: S-EPMC8369015 | biostudies-literature | 2021 Aug
REPOSITORIES: biostudies-literature